Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
32940 | 132 | 22.0 | 38% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
9 | 3 | CHEMISTRY, ORGANIC//JOURNAL OF HETEROCYCLIC CHEMISTRY//KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII | 135847 |
3637 | 2 | NITROBUTADIENES//TERODILINE//5 AZAPYRIMIDINES | 1209 |
32940 | 1 | TERODILINE//BLADDER CONTRACTION INHIBITION//DETRUSOR CONTRACTION INHIBITION | 132 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TERODILINE | authKW | 1332891 | 8% | 52% | 11 |
2 | BLADDER CONTRACTION INHIBITION | authKW | 693990 | 2% | 100% | 3 |
3 | DETRUSOR CONTRACTION INHIBITION | authKW | 693990 | 2% | 100% | 3 |
4 | FK584 | authKW | 520491 | 2% | 75% | 3 |
5 | 1 1 BIPHENYL 2 6 DICARBOXYLIC ACID DIESTER | authKW | 462660 | 2% | 100% | 2 |
6 | 4 4 DIPHENYL 2 CYCLOPENTENYLAMINE | authKW | 462660 | 2% | 100% | 2 |
7 | 1 CYANO 1 PHENYL 1 2 3 4 TETRAHYDROQUINOLIZINIUM CHLORIDE | authKW | 231330 | 1% | 100% | 1 |
8 | 1 CYANO 2 3 DIHYDRO 1 PHENYL 1H INDOLIZINIUM CHLORIDE | authKW | 231330 | 1% | 100% | 1 |
9 | 2 3 DIPHENYL 2 CYCLOPENTENYLAMINE | authKW | 231330 | 1% | 100% | 1 |
10 | 3 PROPANEDIAMINE | authKW | 231330 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 939 | 49% | 0% | 65 |
2 | Toxicology | 424 | 17% | 0% | 23 |
3 | Chemistry, Medicinal | 358 | 16% | 0% | 21 |
4 | Chemistry, Multidisciplinary | 182 | 26% | 0% | 34 |
5 | Chemistry, Organic | 54 | 11% | 0% | 14 |
6 | Spectroscopy | 38 | 5% | 0% | 7 |
7 | Urology & Nephrology | 33 | 5% | 0% | 7 |
8 | Crystallography | 28 | 5% | 0% | 6 |
9 | Obstetrics & Gynecology | 7 | 3% | 0% | 4 |
10 | Chemistry, Analytical | 3 | 4% | 0% | 5 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACEUT PHARMACOKINET S YODOGAWA KU | 231330 | 1% | 100% | 1 |
2 | PHARMACEUT S YODOGAWA KU | 77109 | 1% | 33% | 1 |
3 | FOOD NUTR JOHNAN KU | 23131 | 1% | 10% | 1 |
4 | PROD DEV S | 18503 | 2% | 4% | 2 |
5 | PHARMACEUT SCI 311 MAIDASHI HIGASHI KU | 2926 | 1% | 1% | 1 |
6 | ORGAN POLYMER TECHNOL | 1383 | 1% | 1% | 1 |
7 | ORGAN CHEM BIOCHEM BIOTECHNOL | 672 | 1% | 0% | 1 |
8 | PETR PETROCHEM | 219 | 1% | 0% | 1 |
9 | SCI IND | 186 | 2% | 0% | 2 |
10 | ITABASHI KU | 144 | 2% | 0% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ACTA PHARMACOLOGICA ET TOXICOLOGICA | 9982 | 5% | 1% | 7 |
2 | ACTA PHARMACEUTICA SUECICA | 5682 | 2% | 1% | 3 |
3 | XENOBIOTICA | 2923 | 5% | 0% | 7 |
4 | SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY | 2519 | 5% | 0% | 6 |
5 | PHARMACOLOGY & TOXICOLOGY | 1566 | 3% | 0% | 4 |
6 | BIOMEDICAL MASS SPECTROMETRY | 1449 | 2% | 0% | 2 |
7 | CHEMICAL & PHARMACEUTICAL BULLETIN | 1334 | 8% | 0% | 10 |
8 | ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS | 1209 | 1% | 1% | 1 |
9 | ANALES DE QUIMICA | 1031 | 1% | 0% | 1 |
10 | ORGANIC MAGNETIC RESONANCE | 989 | 2% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LANGTRY, HD , MCTAVISH, D , (1990) TERODILINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES, AND THERAPEUTIC USE IN THE TREATMENT OF URINARY-INCONTINENCE.DRUGS. VOL. 40. ISSUE 5. P. 748-761 | 19 | 68% | 39 |
2 | HARTIGANGO, K , BATEMAN, DN , DALY, AK , THOMAS, SHL , (1996) STEREOSELECTIVE CARDIOTOXIC EFFECTS OF TERODILINE.CLINICAL PHARMACOLOGY & THERAPEUTICS. VOL. 60. ISSUE 1. P. 89-98 | 11 | 65% | 25 |
3 | OGURA, T , JONES, S , SHUBA, LM , MCCULLOUGH, JR , MCDONALD, TF , (1999) BLOCK AND MODIFIED GATING OF CARDIAC CALCIUM CHANNEL CURRENTS BY TERODILINE.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 127. ISSUE 8. P. 1837-1845 | 12 | 52% | 2 |
4 | OYASU, H , NAGANO, M , AKAHANE, A , TOMOI, M , TADA, T , MATSUO, M , (1994) SYNTHESIS AND ANTICHOLINERGIC ACTIVITY OF THE 4 STEREOISOMERS OF 4-(DIMETHYLAMINO)-2-PHENYL-2-(2-PYRIDYL)PENTANAMIDE.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 37. ISSUE 9. P. 1378-1381 | 10 | 71% | 4 |
5 | HALLEN, B , BOGENTOFT, S , SANDQUIST, S , STROMBERG, S , SETTERBERG, G , RYDKJELLEN, E , (1989) TOLERABILITY AND STEADY-STATE PHARMACOKINETICS OF TERODILINE AND ITS MAIN METABOLITES IN ELDERLY PATIENTS WITH URINARY-INCONTINENCE.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 36. ISSUE 5. P. 487-493 | 10 | 77% | 13 |
6 | HALLEN, B , GABRIELSSON, J , NYAMBATI, S , JOHANSSON, A , LARSSON, E , GUILBAUD, O , (1995) CONCOMITANT SINGLE-DOSE AND MULTIPLE-DOSE PHARMACOKINETICS OF TERODILINE IN MAN, WITH A NOTE ON ITS ENANTIOMERS AND MAJOR METABOLITES.PHARMACOLOGY & TOXICOLOGY. VOL. 76. ISSUE 3. P. 171-177 | 7 | 78% | 5 |
7 | BECKETT, AH , NAVAS, GE , HUTT, AJ , (1988) METABOLISM OF CHLORPROMAZINE AND PROMAZINE INVITRO - ISOLATION AND CHARACTERIZATION OF N-OXIDATION PRODUCTS.XENOBIOTICA. VOL. 18. ISSUE 1. P. 61-74 | 8 | 89% | 8 |
8 | HALLEN, B , GABRIELSSON, J , PALMER, L , EKSTROM, B , (1993) PHARMACOKINETICS OF R(+)-TERODILINE GIVEN INTRAVENOUSLY AND ORALLY TO HEALTHY-VOLUNTEERS.PHARMACOLOGY & TOXICOLOGY. VOL. 73. ISSUE 3. P. 153-158 | 8 | 62% | 6 |
9 | TANIGUCHI, K , OKUMURA, K , TAKE, K , TSUBAKI, K , TERAI, T , NAKANISHI, I , SHIOKAWA, Y , (1995) AGENTS FOR THE TREATMENT OF OVERACTIVE DETRUSOR .8. SYNTHESIS AND PHARMACOLOGICAL PROPERTIES OF 4,4-DIPHENYL-2-CYCLOALKENYLAMINES INCLUDING FK584 AND 3,3-DIPHENYLCYCLOALKYLAMINES OR 4,4-DIPHENYLCYCLOALKYLAMINES.CHEMICAL & PHARMACEUTICAL BULLETIN. VOL. 43. ISSUE 1. P. 71-77 | 7 | 64% | 1 |
10 | TAKE, K , OKUMURA, K , TAKIMOTO, K , OHTSUKA, M , SHIOKAWA, Y , (1992) AGENTS FOR THE TREATMENT OF OVERACTIVE DETRUSOR .2. SYNTHESIS AND INHIBITORY ACTIVITY ON DETRUSOR CONTRACTION OF 1,1'-BIPHENYL-2,6-DICARBOXYLIC ACID DIESTERS WITH AN AMINOALKYL GROUP IN THE ESTER FUNCTION.CHEMICAL & PHARMACEUTICAL BULLETIN. VOL. 40. ISSUE 4. P. 899 -906 | 5 | 100% | 4 |
Classes with closest relation at Level 1 |